Resident 51 went without her prescribed oxycodone from August 28 through August 31, when the facility finally received a new supply from the pharmacy. The original medication card disappeared around August 29, according to staff statements reviewed by state inspectors.
The resident directly accused RN 227 of theft. But when the unit manager called the nurse to verify medication administration, facility leaders considered the matter resolved.
Regional Nurse 200 confirmed during a September 17 interview that the facility had "no summary or conclusion of their investigation into the allegation of missing narcotics for Resident 51."
The missing oxycodone was just one piece of a larger pattern of controlled substance mismanagement that inspectors uncovered during their September investigation.
On August 28, the same day Resident 51's pain medication vanished, RN 227 improperly logged controlled substances for another patient. Two sheets and two cards of Alprazolam arrived for Resident 81 — one containing 30 pills, another with 15 pills. The nurse signed only one sheet and one card into the facility's narcotic count system.
LPN/Unit Manager 175 explained the significance: "This would make the count wrong unless a card and sheet were removed by someone."
The faulty logging created a perfect cover for theft. By failing to record both deliveries, someone could remove the unrecorded medications without affecting the official count.
Regional Nurse 200 acknowledged the facility never investigated this Alprazolam logging error, despite its connection to the timeframe when Resident 51's oxycodone disappeared.
When the initial allegation surfaced on September 3, administrators drug tested RN 227. The test came back negative on September 6. But the nurse continued working regular day shifts on B-Hall through at least September 17, when inspectors observed her on duty.
The facility's response to the missing narcotics revealed broader systematic failures in oversight and quality assurance.
Regional Nurse 200 admitted she provided staff education about narcotic handling on September 3, calling the situation "a mess." The pharmacy was notified the same day but played no role in investigating the missing controlled substances.
More troubling, facility leadership appeared unaware of the scope of problems under their supervision.
Administrator 188 and Regional Director of Operations 350 confirmed during a September 29 interview that they knew nothing about multiple serious issues inspectors had identified. These included not just the missing narcotics, but also a failure to provide ordered transportation and medication for Resident 79 that resulted in bone infection, failure to recognize severe dehydration in Resident 95 that contributed to death, and significant medication errors affecting Residents 3 and 40.
The facility's Quality Assurance and Performance Improvement committee, designed to catch exactly these kinds of problems, had failed completely.
Administrator 188 confirmed there were no attendance records for QAPI meetings. The September 3 QAPI meeting — held the same day staff learned about missing narcotics — identified no issues with controlled substance misappropriation.
Regional Director of Operations 350 and Regional Director of Clinical Services 201 told inspectors during their September 29 interview that they had no prior knowledge of any of the serious care failures the survey team uncovered.
The facility's own policy, dated July 2016, required the QAPI committee to "establish, maintain, and oversee facility systems and processes to support the delivery of quality of care and services" and "help identify actual and potential negative outcomes relative to resident care and resolve them appropriately."
The policy specifically called for root cause analysis to identify "where patterns of negative outcomes point to underlying systemic problems" and coordination of "performance improvement projects to achieve specific goals."
None of this happened.
There was no evidence the governing body participated in any QAPI meetings, despite policy requirements for regular reporting to facility leadership.
Administrator 188 also confirmed the facility failed to document weekly meetings about a transportation contract, suggesting the oversight failures extended beyond clinical care into basic operational management.
The controlled substance violations affected multiple residents across different units and involved different types of medications, indicating the problems weren't isolated to a single nurse or incident.
For Resident 51, the missing oxycodone meant three days without prescribed pain relief. For Resident 81, the improper logging created vulnerabilities in medication security that could have affected future prescriptions.
The facility's investigation process broke down at every level. Initial allegations weren't properly documented. Follow-up inquiries consisted of a single phone call to the accused nurse. Drug testing occurred but wasn't part of a comprehensive investigation plan.
Regional leadership, responsible for overseeing multiple facilities, remained unaware of serious care failures until state inspectors arrived. The disconnect between corporate oversight and facility operations left residents vulnerable to medication theft, untreated medical conditions, and medication errors.
The September inspection revealed that Country Lane Gardens' quality assurance system existed primarily on paper. Meetings occurred without documentation, investigations concluded without findings, and serious allegations were dismissed without proper review.
Resident 51's direct accusation that RN 227 was stealing medication should have triggered immediate and thorough investigation protocols. Instead, it prompted a single verification call and business as usual.
The missing oxycodone case exemplified a facility where controlled substance security had become so lax that medications could disappear without consequence, residents could go days without prescribed pain relief, and staff could manipulate narcotic counts without detection.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Country Lane Gardens Rehab & Nursing Ctr from 2025-10-15 including all violations, facility responses, and corrective action plans.
Additional Resources
- View all inspection reports for Country Lane Gardens Rehab & Nursing Ctr
- Browse all OH nursing home inspections